David R. Liu
No más puestos en curso
Perfil
David R.
Liu is the founder of Beam Therapeutics, Inc. (founded in 2017) and Chroma Medicine, Inc. (founded in 2020).
He previously worked as a Director at Terns Pharmaceuticals, Inc.
Antiguos cargos conocidos de David R. Liu.
| Empresas | Cargo | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | - |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Fundador | - |
| BEAM THERAPEUTICS INC. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BEAM THERAPEUTICS INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
- Bolsa de valores
- Insiders
- David R. Liu
